IP Library Granted Patent US 12,465,255
Granted Patent B1
US 12,465,255 · App. 17/695,942 · Granted Nov 11, 2025

Method and system for deriving a pressure flow study score and components thereof

Inventor: Lee Brody (Somerville, MA)
Assignee: SRS Medical Systems, LLC
A61B5/208A61B5/391A61B5/7475
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,465,255
App. No.
17/695,942
Granted
Nov 11, 2025
Kind
B1
Abstract

A method of assessing pressure flow study data is provided. The method is characterized by obtaining a select weighted average composite of select derived symptom sub-scores via use of a urodynamic system characterized by, in operative combination, a processor, memory and symptom score software executable by the processor, the urodynamic system receiving input from at least pressure and urine flow sensing devices. A flow rate efficiency sub-score is derived, along with a voided urine volume sub-score, a post void residual sub-score, a flow pattern sub-score and a pressure pattern sub-score.

Claims (21)

1 . A method of assessing pressure flow study data for lower urinary tract symptom determination wherein voiding pressure and resulting urine flow rate determinations are obtained during a void event using a urodynamic system characterized by, in operative combination, a processor, memory and symptom score software executable by the processor, the urodynamic system receiving input from at least pressure and urine flow sensing devices in furtherance of ascertaining a maximum urine discharge flow rate, a maximum vesical pressure value, and a total volume of voided urine, comprising the steps of:

a. deriving a first primary symptom sub-score comprised of a flow rate efficiency symptom sub-score predicted upon a maximum vesical pressure value sensed via the pressure sensing device and upon a maximum urine discharge flow rate determined via the urine flow sensing device, or derivable from collected voided volume urine quantity as a function of time during a void event;

b. deriving a second primary symptom sub-score comprised of a post void residual symptom sub-score predicted upon a relationship between a measured voided volume of urine and a measured or sensed residual volume of urine remaining in a bladder post void;

c. deriving a third primary symptom sub-score comprised of a voided volume sub-score predicated upon the measured voided volume of urine;

d. deriving a first secondary symptom sub-score comprised of a flow pattern symptom sub-score predicated upon a relationship for, between and/or among a measured urine void time value, a derived hesitancy value based upon a sensing of one or more no flow conditions during a urine void event, a time to peak measured urine discharge flow, and the maximum urine discharge flow rate;

e. deriving a second secondary symptom sub-score comprised of a pressure pattern sub-score predicated flow rate efficiency and measured maximum pressure; and,

f. selectively combining select symptom sub-scores to obtain a symptom score comprising a select weighted average composite of select symptom sub-scores.

2 . The method of claim 1 wherein the selective combining of select symptom sub-scores emphasizes either of the flow rate efficiency symptom sub-score or the voided urine volume symptom sub-score.

3 . The method of claim 1 wherein the selective combining of select symptom sub-scores emphasizes both of the flow rate efficiency symptom sub-score and the voided urine volume symptom sub-score.

4 . The method of claim 1 wherein the selective combining of select symptom sub-scores comprises a hierarchical weighting of select symptom sub-scores to yield the select weighted average composite.

5 . The method of claim 1 wherein components of the pressure pattern sub-score comprise each of a shape of a curve associated with a plot of applied pressure as a function of time, a consistency of a proportional relationship between applied pressure and urine discharge flow rate, and maximum applied pressure.

6 . The method of claim 1 further comprising deriving an abdominal straining sub-score.

7 . The method of claim 1 further comprising deriving an abdominal straining sub-score, said abdominal straining sub-score reflective of plural components.

8 . The method of claim 1 further comprising deriving an abdominal straining sub-score, said abdominal straining sub-score reflective of plural components, the plural components comprising abdominal electromyography values obtained during pressure flow study performance and abdominal electromyography values obtained during performance of a simulated strain protocol.

9 . A urodynamic system for deriving a symptom score to augment findings associated with a pressure flow study for lower urinary tract symptom determination, the system comprising:

a. a processor for processing select urodynamic patient parameter inputs;

b. a database accessible by said processor;

c. a user interface device operably linked to said processor in furtherance of supporting processor control and/or display of patient parameter inputs/select processed urodynamic patient parameter inputs;

d. a pressure sensor for sensing vesical pressure during bladder filling and/or emptying, said select urodynamic patient parameter inputs characterized by pressure values obtained via said pressure sensor;

e. apparatus for deriving urine flow rate, said select urodynamic patient parameter inputs characterized by urine flow rate obtained via said apparatus for determining urine flow rate; and,

f. a symptom score derivation module operably linked/linkable with said processor, said database and said user interface device, said symptom score derivation module executing steps of deriving select symptom sub-scores characterized by two or more of a flow rate efficiency symptom sub-score, a post void residual symptom sub-score, a voided urine volume symptom sub-score, a flow pattern symptom sub-score, and a pressure pattern symptom sub-score, said flow rate efficiency sub-score predicted upon a maximum vesical pressure value sensed via the pressure sensor and upon a maximum urine discharge flow rate determined via the apparatus for deriving urine flow rate, said post void residual symptom subs-score predicted upon a relationship between a measured voided volume of urine and a measured or sensed residual volume of urine remaining in a bladder post void, said voided volume symptom sub-score predicated upon the measured voided volume of urine, said flow pattern symptom sub-score predicated upon a relationship for, between and/or among a measured urine void time value, a derived hesitancy value based upon a sensing of one or more no flow conditions during a urine void event, a time to peak measured urine discharge flow, and the maximum urine discharge flow rate, and said pressure pattern symptom sub-score predicated flow rate efficiency and measured maximum pressure, the symptom score comprising a select weighted average composite of select symptom sub-scores.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 20, 2022
From: BRODY, LEE
To: SRS MEDICAL SYSTEMS, LLC
Reel/Frame 059650/0433 →
Continuity (1)
Provisional Application 63162084 · Mar 17, 2021
References Cited (29)
US 6719709B2 · Whalen · 2004 [cited by examiner]
US 7147606B1 · Chang · 2006 [cited by examiner]
US 7522061B2 · Rondoni · 2009 [cited by examiner]
US 7833142B2 · Karp · 2010 [cited by examiner]
US 8597184B2 · Addington · 2013 [cited by examiner]
US 9101314B2 · Shi · 2015 [cited by examiner]
US 11207012B2 · Belotserkovsky · 2021 [cited by examiner]
US 11224719B2 · Brody · 2022 [cited by applicant]
US 12295732B2 · Beer · 2025 [cited by examiner]
US 12337173B2 · Potts · 2025 [cited by examiner]
US 20060122488A1 · Kajbafzadeh · 2006 [cited by examiner]
US 20060276712A1 · Stothers · 2006 [cited by examiner]
US 20070225616A1 · Brown · 2007 [cited by examiner]
US 20080262389A1 · Shahar · 2008 [cited by examiner]
US 20080300649A1 · Gerber · 2008 [cited by examiner]
US 20100152684A1 · Kim · 2010 [cited by examiner]
US 20140107432A1 · Bastia · 2014 [cited by examiner]
US 20140228654A1 · Kim · 2014 [cited by examiner]
US 20140316219A1 · Paz · 2014 [cited by examiner]
US 20140330546A1 · Deng · 2014 [cited by examiner]
US 20170055874A1 · Papirov · 2017 [cited by examiner]
US 20180214122A1 · Ansell · 2018 [cited by examiner]
US 20190008439A1 · Sageder · 2019 [cited by examiner]
US 20190046101A1 · Tsukada · 2019 [cited by examiner]
US 20190110733A1 · Pop · 2019 [cited by examiner]
US 20190246937A1 · Chow · 2019 [cited by examiner]
US 20200268302A1 · Oh · 2020 [cited by examiner]
US 20210186399A1 · Gunderson · 2021 [cited by examiner]
Kaplan et al., “Noninvasive Pressure Flow Studies in the Evaluation of Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Review of 50,000 Patients,” The Journal of Urology, vol. 204, 129… [cited by applicant]